Teva Pharmaceutical Industries

Welcome to the 'Teva Pharmaceutical Industries' tag page at Technorati. This page features content from the farthest reaches of the Blogosphere that authors have "tagged" with 'Teva Pharmaceutical Industries'.

Latest blogosphere posts tagged “Teva Pharmaceutical Industries”

• (CEPH) Cephalon Inc Sues Teva Pharmaceuticals

  
  Stock Blog Hub — Authority: 460
  Recently, Cephalon, Inc. ( CEPH ) filed a patent infringement lawsuit against generic player Teva Pharmaceuticals ( TEVA ), which is seeking to market a generic version of Cephalon’s sleep franchise product, Nuvigil. The lawsuit was filed in response to a Paragraph IV Certification Notice Letter received by ...
  1 day ago

• (ABT) Abbott Laboratories Settles Dispute with Teva Pharmaceutical Industries

  
  Stock Blog Hub — Authority: 460
  In a filing with the U.S. Securities and Exchange Commission (SEC), Abbott Laboratories Inc. ( ABT ) announced that it has settled its patent litigation with Teva Pharmaceutical Industries Ltd. ( TEVA ), which was seeking to market generic versions of Abbott’s TriCor. According to the agreement between the ...
  2 days ago

• (BMRN) BioMarin Pharmaceutical Earns Orphan Status From FDA

  
  Stock Blog Hub — Authority: 460
  Recently, BioMarin Pharmaceutical Inc. ( BMRN ) announced that the U.S. Food and Drug Administration (FDA) granted orphan drug status to its candidate 3,4-diaminopyridine amifampridine phosphate (3,4-DAP), for the treatment of Lambert Eaton Myasthenic Syndrome (LEMS). As a reminder, BioMarin acquired the privately ...
  4 days ago

• ($SNY) Sanofi Beats Expectations on Higher Revenue

  
  Stock Blog Hub — Authority: 460
  Sanofi-Aventis ( SNY ) recently reported third quarter earnings of $1.25 per American Depository Share (ADS), 4 cents above the Zacks Consensus Estimate of $1.21. The company reported earnings of $1.06 in the year-ago period. Revenue increased 6% with performance being driven by Lovenox (up 13.7%), Lantus (up 21.7%) ...
  1 week ago

• (CEPH) Cephalon Settles Barr Pharmaceuticals Challenge

  
  Stock Blog Hub — Authority: 460
  Earlier this month, Cephalon Inc. ( CEPH ) announced that it has settled its patent infringement case with Barr Pharmaceuticals, which is now owned by Teva Pharmaceutical ( TEVA ). Barr was looking to market a generic version of Cephalon’s cancer pain management drug, Fentora. As per the terms of the agreement, ...
  1 week ago

• Omnicare, IVAX Settle

  
  Health Fitness & Beauty - health-fitness.marc8.com — Authority: 160
  Settlements and kickbacks and corporate integrity agreements, oh my (to the tune of "lions and tigers and bears, oh my") To quote the BusinessWeek version of the story: A $112 million settlement involving alleged drug kickbacks that the Justice Dept. announced with the nations largest nursing home pharmacy and a ...
  3 weeks ago

• (TEVA) Teva Pharmaceutical Industries Reports Strong Quarter

  
  Stock Blog Hub — Authority: 460
  Teva Pharmaceutical Industries Ltd. ( TEVA ) reported earnings of 89 cents in the third quarter of 2009, up 16% from the year-ago period and a cent above the Zacks Consensus Estimate. Strong sales of Copaxone and in the respiratory business helped drive earnings in the reported quarter. Net sales increased 25% to ...
  4 weeks ago

• ($CEPH) Cephalon Beats Forecasts – Provides Outlook

  
  Stock Blog Hub — Authority: 460
  Cephalon Inc. ( CEPH ) reported strong third-quarter earnings of $1.62 per share that easily surpassed the Zacks Consensus Estimate of $1.42 per share and the year ago earnings of $1.18. Revenues increased 10.2% to $549 million, consisting of $535 million in product sales and $14.2 million in other revenues. Higher ...
  5 weeks ago

• (BMRN) BioMarin Pharmaceutical Purchases Huxley Pharmaceuticals

  
  Stock Blog Hub — Authority: 460
  Recently, BioMarin Pharmaceutical Inc. ( BMRN ) announced that it has acquired the privately held Huxley Pharmaceuticals Inc., which possessed rights to a proprietary form of 3,4-diaminopyridine amifampridine phosphate ( 3,4-DAP), for the treatment of Lambert Eaton Myasthenic Syndrome (LEMS). Under the terms of the ...
  5 weeks ago

• (CEPH) Cephalon’s Nuvigil Faces Generic Threat Teva Pharmaceuticals

  
  Stock Blog Hub — Authority: 460
  Cephalon, Inc. (CEPH) recently received a Paragraph IV Certification Notice Letter regarding an Abbreviated New Drug Application (ANDA), which has been filed by Teva Pharmaceuticals (TEVA) with the U.S. Food and Drug Administration (FDA). Generic player, Teva, is looking to market and sell its generic version of ...
  5 weeks ago

Comments about Teva Pharmaceutical Industries